Literature DB >> 23398272

Affective temperaments and psychopathological dimensions of personality in bipolar and cyclothymic patients.

Désirée Harnic1, Maurizio Pompili, Marianna Mazza, Marco Innamorati, Marco Di Nicola, Valeria Catalano, Angelo Bruschi, Diletta Del Bono, Alberto Forte, David Lester, Paolo Girardi, Pietro Bria, Luigi Janiri.   

Abstract

The aims of the study were: (1) to study possible associations between temperament, personality dimensions, and psychopathological variables in a clinical sample of euthymic patients with bipolar disorder (BD) and cyclothymia; and (2) to assess how Cloninger's temperament and personality dimensions were associated with affective temperaments. Participants, consisting of 60 patients with BD (type I or II) and cyclothymia in the euthymic phase, completed Akiskal's Temperament Evaluation of Memphis, Pisa, Paris, and San Diego-Autoquestionnaire (TEMPS-A), and Cloninger's Temperament and Character Inventory-revised version (TCI-R). The diagnostic groups differed in past hospitalization, for age at onset of the disorder, and on two affective temperaments: the TEMPS-A Hyperthymia, and the TEMPS-A Irritability. There were six significant associations between affective temperaments and Cloninger's personality dimensions, ranging from 0.26 to 0.54. The measures of Akiskal and of Cloninger tap common behavioral features in patients with bipolar disorder and cyclothymia, yet the differences indicate that the two measures are not redundant. BD and cyclothymic patients differed significantly in temperament and personality, differences that may have important implications for treatment.

Entities:  

Mesh:

Year:  2013        PMID: 23398272     DOI: 10.1080/08964289.2012.713043

Source DB:  PubMed          Journal:  Behav Med        ISSN: 0896-4289            Impact factor:   3.104


  1 in total

1.  Relationship Between Temperament and Character Traits, Mood, and Medications in Bipolar I Disorder.

Authors:  Sergio B Chavez; Luis A Alvarado; Robert Gonzalez
Journal:  Prim Care Companion CNS Disord       Date:  2016-06-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.